CompoAtlas

AnxioZen

Food supplement declared in France, declaration No 2016-6-643, decision dated 20 June 2016

AnxioZen (Synergia) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
Synergia
Food business operator placing the product on the market
CURAE NUTRI
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Flacon
Daily dose
20 ml
Directions for use
10 ml le matin et 10 ml le soir
Not recommended for (according to the manufacturer)
Enfants en bas âge (1 à 3 ans)
Objectives stated by the manufacturer (these are not authorised claims)
Sommeil, Humeur

Declaration 155331, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Crataegus laevigata (Poir.) DC.Sommités fleuriesMacérât hydroalcoolique1.6 g
Melissa officinalis L.Parties aériennesMacérât hydroalcoolique1.6 g
Passiflora incarnata L.Parties aériennesMacérât hydroalcoolique1.6 g

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

List recorded in 2016. Photograph the packaging to check whether it has changed. Photograph the packaging

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Synergia

List recorded in 2016. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line